The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits

Virus Research

Volumn 129, Issue 2, 2007, Pages 200-211

  Visalli, Robert J ^a   Nicolosi, Denise M ^a   Irven, Karen L ^a   Goshorn, Bradley ^a   Khan, Tamseel ^a   Visalli, Melissa A ^a  

^a INDIANA UNIVERSITY PURDUE UNIVERSITY FORT WAYNE   (United States)

Author keywords

DNA encapsidation; ORF30; ORF45 42; Terminase; Varicella zoster virus

Indexed keywords

GENE PRODUCT; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VARICELLA ZOSTER VIRUS; VIRAL GENETICS; VIRUS CAPSID; VIRUS GENE; VIRUS STRAIN;

ANIMALS; CELL LINE; ENDODEOXYRIBONUCLEASES; GENES, VIRAL; HERPESVIRUS 3, HUMAN; HUMANS; OPEN READING FRAMES; PROTEIN SUBUNITS; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 5;

EID: 35348921131     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.07.015     Document Type: Article

References (62)

1. Abbotts A.P., Preston V.G., Hughes M., Patel A.H., and Stow N.D. Interaction of the herpes simplex virus type 1 packaging protein UL15 with full-length and deleted forms of the UL28 protein. J. Gen. Virol. 81 Pt 12 (2000) 2999-3009
2. Alba M.M., Das R., Orengo C.A., and Kellam P. Genomewide function conservation and phylogeny in the Herpesviridae. Genome Res. 11 1 (2001) 43-54
3. Baines J.D., and Roizman B. The cDNA of UL15, a highly conserved herpes simplex virus 1 gene, effectively replaces the two exons of the wild-type virus. J. Virol. 66 9 (1992) 5621-5626
4. Beard P.M., Taus N.S., and Baines J.D. DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells. J. Virol. 76 10 (2002) 4785-4791
5. Biron K.K. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71 2/3 (2006) 154-163
6. Biron K.K., Harvey R.J., Chamberlain S.C., Good S.S., Smith I.A., Davis M.G., Talarico C.L., Miller W.H., Ferris R., Dornsife R.E., Stanat S.C., Drach J.C., Townsend L.B., and Koszalka G.W. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46 8 (2002) 2365-2372
7. Bogner E. Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev. Med. Virol. 12 2 (2002) 115-127
8. Bogner E., Radsak K., and Stinski M.F. The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J. Virol. 72 3 (1998) 2259-2264
9. Brown, J.M., Homa, F.L., 2002. Packaging DNA into herpesvirus capsids. In: B. Holzenburg (Ed.), Structure-Function Relationships of Human Pathogenic Viruses. Kluwer academic/Plenum, New York, pp. 111-153.
10. Buerger I., Reefschlaeger J., Bender W., Eckenberg P., Popp A., Weber O., Graeper S., Klenk H.D., Ruebsamen-Waigmann H., and Hallenberger S. A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J. Virol. 75 19 (2001) 9077-9086
11. Casper C. Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection. Herpes 13 2 (2006) 42-47
12. Casper C., and Wald A. The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma. Curr. Top. Microbiol. Immunol. 312 (2007) 289-307
13. Chang Y.E., Poon A.P., and Roizman B. Properties of the protein encoded by the UL32 open reading frame of herpes simplex virus 1. J. Virol. 70 6 (1996) 3938-3946
14. Davison A.J., and Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67 Pt 9 (1986) 1759-1816
15. De Clercq E. Antiviral drugs: current state of the art. J. Clin. Virol. 22 1 (2001) 73-89
16. Di Grandi M.J., Bloom J.D., Curran K.J., Feigelson G., Prashad A., Ross A.A., Visalli R.J., and Feld B. Thiourea inhibitors of herpesviruses. Part 3. Inhibitors of VZV. Bioorg. Med. Chem. Lett. 16 14 (2004) 4157-4160
17. Dittmer A., Drach J.C., Townsend L.B., Fischer A., and Bogner E. Interaction of the putative human cytomegalovirus portal protein pUL104 with the large terminase subunit pUL56 and its inhibition by benzimidazole-d-ribonucleosides. J. Virol. 79 23 (2005) 14660-14667
18. Dolan A., Arbuckle M., and McGeoch D.J. Sequence analysis of the splice junction in the transcript of herpes simplex virus type 1 gene UL15. Virus Res. 20 1 (1991) 97-104
19. Evers D.L., Komazin G., Shin D., Hwang D.D., Townsend L.B., and Drach J.C. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus. Antiviral Res. 56 1 (2002) 61-72
20. Goshima F., Watanabe D., Takakuwa H., Wada K., Daikoku T., Yamada M., and Nishiyama Y. Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells. Arch. Virol. 145 2 (2000) 417-426
21. Griffiths P.D. Antivirals in the transplant setting. Antiviral Res. 71 2/3 (2006) 192-200
22. Hwang J.S., and Bogner E. ATPase activity of the terminase subunit pUL56 of human cytomegalovirus. J. Biol. Chem. 277 9 (2002) 6943-6948
23. Jacobson J.G., Yang K., Baines J.D., and Homa F.L. Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation. J. Virol. 80 24 (2006) 12312-12323
24. Kinchington P.R., Hougland J.K., Arvin A.M., Ruyechan W.T., and Hay J. The Varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol. 66 1 (1992) 359-366
25. Koslowski K.M., Shaver P.R., Casey II J.T., Wilson T., Yamanaka G., Sheaffer A.K., Tenney D.J., and Pederson N.E. Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins. J. Virol. 73 2 (1999) 1704-1707
26. Koslowski K.M., Shaver P.R., Wang X.Y., Tenney D.J., and Pederson N.E. The pseudorabies virus UL28 protein enters the nucleus after coexpression with the herpes simplex virus UL15 protein. J. Virol. 71 12 (1997) 9118-9123
27. Krosky P.M., Underwood M.R., Turk S.R., Feng K.W., Jain R.K., Ptak R.G., Westerman A.C., Biron K.K., Townsend L.B., and Drach J.C. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72 6 (1998) 4721-4728
28. Lamberti C., and Weller S.K. The herpes simplex virus type 1 UL6 protein is essential for cleavage and packaging but not for genomic inversion. Virology 226 2 (1996) 403-407
29. Lamberti C., and Weller S.K. The herpes simplex virus type 1 cleavage/packaging protein, UL32, is involved in efficient localization of capsids to replication compartments. J. Virol. 72 3 (1998) 2463-2473
30. Luck S., Sharland M., Griffiths P., and Jenkins S.M. Advances in the antiviral therapy of herpes virus infection in children. Expert Rev. Anti Infect. Ther. 4 6 (2006) 1005-1020
31. McNab A.R., Desai P., Person S., Roof L.L., Thomsen D.R., Newcomb W.W., Brown J.C., and Homa F.L. The product of the herpes simplex virus type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA. J. Virol. 72 2 (1998) 1060-1070
32. Newcomb W.W., and Brown J.C. Inhibition of herpes simplex virus replication by WAY-150138: assembly of capsids depleted of the portal and terminase proteins involved in DNA encapsidation. J. Virol. 76 19 (2002) 10084-10088
33. Newcomb W.W., Homa F.L., Thomsen D.R., and Brown J.C. In vitro assembly of the herpes simplex virus procapsid: formation of small procapsids at reduced scaffolding protein concentration. J. Struct. Biol. 133 1 (2001) 23-31
34. Newcomb W.W., Juhas R.M., Thomsen D.R., Homa F.L., Burch A.D., Weller S.K., and Brown J.C. The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid. J. Virol. 75 22 (2001) 10923-10932
35. Ogasawara M., Suzutani T., Yoshida I., and Azuma M. Role of the UL25 gene product in packaging DNA into the herpes simplex virus capsid: location of UL25 product in the capsid and demonstration that it binds DNA. J. Virol. 75 3 (2001) 1427-1436
36. Patel A.H., and MacLean J.B. The product of the UL6 gene of herpes simplex virus type 1 is associated with virus capsids. Virology 206 1 (1995) 465-478
37. Patel A.H., Rixon F.J., Cunningham C., and Davison A.J. Isolation and characterization of herpes simplex virus type 1 mutants defective in the UL6 gene. Virology 217 1 (1996) 111-123
38. Proux-Gillardeaux V., Galli T., Callebaut I., Mikhailik A., Calothy G., and Marx M. D53 is a novel endosomal SNARE-binding protein that enhances interaction of syntaxin 1 with the synaptobrevin 2 complex in vitro. Biochem. J. 370 Pt 1 (2003) 213-221
39. Reefschlaeger J., Bender W., Hallenberger S., Weber O., Eckenberg P., Goldmann S., Haerter M., Buerger I., Trappe J., Herrington J.A., Haebich D., and Ruebsamen-Waigmann H. Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. J. Antimicrob. Chemother. 48 6 (2001) 757-767
40. Reynolds A.E., Fan Y., and Baines J.D. Characterization of the U(L)33 gene product of herpes simplex virus 1. Virology 266 2 (2000) 310-318
41. Salmon B., and Baines J.D. Herpes simplex virus DNA cleavage and packaging: association of multiple forms of U(L)15-encoded proteins with B capsids requires at least the U(L)6, U(L)17, and U(L)28 genes. J. Virol. 72 4 (1998) 3045-3050
42. Schang L.M. Herpes simplex viruses in antiviral drug discovery. Curr. Pharm. Des. 12 11 (2006) 1357-1370
43. Scheffczik H., Savva C.G., Holzenburg A., Kolesnikova L., and Bogner E. The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucl. Acids Res. 30 7 (2002) 1695-1703
44. Scholz B., Rechter S., Drach J.C., Townsend L.B., and Bogner E. Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucl. Acids Res. 31 5 (2003) 1426-1433
45. Severini A., Scraba D.G., and Tyrrell D.L. Branched structures in the intracellular DNA of herpes simplex virus type 1. J. Virol. 70 5 (1996) 3169-3175
46. Sheaffer A.K., Newcomb W.W., Gao M., Yu D., Weller S.K., Brown J.C., and Tenney D.J. Herpes simplex virus DNA cleavage and packaging proteins associate with the procapsid prior to its maturation. J. Virol. 75 2 (2001) 687-698
47. Taus N.S., and Baines J.D. Herpes simplex virus 1 DNA cleavage/packaging: the UL28 gene encodes a minor component of B capsids. Virology 252 2 (1998) 443-449
48. Thoma C., Borst E., Messerle M., Rieger M., Hwang J.S., and Bogner E. Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. Biochemistry 45 29 (2006) 8855-8863
49. Townsend L.B., Devivar R.V., Turk S.R., Nassiri M.R., and Drach J.C. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-d-ribofuranosyl)benzimidazoles. J. Med. Chem. 38 20 (1995) 4098-4105
50. Underwood M.R., Harvey R.J., Stanat S.C., Hemphill M.L., Miller T., Drach J.C., Townsend L.B., and Biron K.K. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72 1 (1998) 717-725
51. van Zeijl M., Fairhurst J., Jones T.R., Vernon S.K., Morin J., LaRocque J., Feld B., O'Hara B., Bloom J.D., and Johann S.V. Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. J. Virol. 74 19 (2000) 9054-9061
52. Visalli R.J. Novel compounds for the treatment of varicella-zoster virus infections. Expert Opin. Ther. Patents 14 3 (2004) 355-365
53. Visalli R.J., Fairhurst J., Srinivas S., Hu W., Feld B., DiGrandi M., Curran K., Ross A., Bloom J.D., van Zeijl M., Jones T.R., O'Connell J., and Cohen J.I. Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication. J. Virol. 77 4 (2003) 2349-2358
54. Visalli R.J., and van Zeijl M. DNA encapsidation as a target for anti-herpesvirus drug therapy. Antiviral Res. 59 2 (2003) 73-87
55. Weber O., Bender W., Eckenberg P., Goldmann S., Haerter M., Hallenberger S., Henninger K., Reefschlager J., Trappe J., Witt-Laido A., and Ruebsamen-Waigmann H. Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo. Antiviral Res. 49 3 (2001) 179-189
56. White C.A., Stow N.D., Patel A.H., Hughes M., and Preston V.G. Herpes simplex virus type 1 portal protein UL6 interacts with the putative terminase subunits UL15 and UL28. J. Virol. 77 11 (2003) 6351-6358
57. Wills E., Scholtes L., and Baines J.D. Herpes simplex virus 1 DNA packaging proteins encoded by UL6, UL15, UL17, UL28, and UL33 are located on the external surface of the viral capsid. J. Virol. 80 21 (2006) 10894-10899
58. Yang K., and Baines J.D. The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. J. Virol. 80 12 (2006) 5733-5739
59. Yang K., Homa F., and Baines J.D. Putative terminase subunit of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus. J. Virol. 81 12 (2007) 6419-6433
60. Yu D., and Weller S.K. Genetic analysis of the UL 15 gene locus for the putative terminase of herpes simplex virus type 1. Virology 243 1 (1998) 32-44
61. Yu D., and Weller S.K. Herpes simplex virus type 1 cleavage and packaging proteins UL15 and UL28 are associated with B but not C capsids during packaging. J. Virol. 72 9 (1998) 7428-7439
62. Zhang X., Efstathiou S., and Simmons A. Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies. Virology 202 2 (1994) 530-539